Early onset of acute lymphoblastic leukemia with MLL rearrangement after autologous stem cell transplantation for multiple myeloma.
Ueda
Koki
K
Yamamoto
Go
G
Shinohara
Akihito
A
Hangaishi
Akira
A
Kurokawa
Mineo
M
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D005260:Female; D015321:Gene Rearrangement; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D008558:Melphalan / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000628:therapy; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000209:etiology / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics
D018906:Antineoplastic Agents, Alkylating; C497422:KMT2A protein, human; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase; D008558:Melphalan